Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. (MGTA) Revenue
Annual & quarterly revenue history · segment & region breakdown
MGTA · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsMagenta Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
BiotechnologyCompare MGTA revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Magenta Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Magenta Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Magenta Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MGTA revenue · 4 questionsMGTA's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Magenta Therapeutics, Inc. SEC filings · GAAP · Magenta Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026